Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 4, 2008, Pages 895-901

  Bageman, Erika ^a   Ingvar, Christian ^b   Rose, Carsten ^b   Jernström, Helena ^a,b,c  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c MALMÖ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A2; ESTROGEN RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; COFFEE; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DRINKING; FEMALE; FOOD INTAKE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; ONSET AGE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUESTIONNAIRE; SWEDEN;

AGE OF ONSET; BREAST NEOPLASMS; COFFEE; CYTOCHROME P-450 CYP1A2; FEMALE; GENOTYPE; HUMANS; LIFE STYLE; LOGISTIC MODELS; MIDDLE AGED; QUESTIONNAIRES; RECEPTORS, ESTROGEN; SWEDEN;

EID: 42149088261     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0555     Document Type: Article

References (42)

1. Baker JA, Beehler GP, Sawant AC, et al. Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. J Nutr 2006;136:166-71.
2. Nkondjock A, Ghadirian P, Kotsopoulos J, et al. Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Int J Cancer 2006;118:103-7.
3. Vatten LJ, Solvoll K, Loken EB. Coffee consumption and the risk of breast cancer. A prospective study of 14,593 Norwegian women. Br J Cancer 1990;62:267-70.
4. Michels KB, Holmberg L, Bergkvist L, Wolk A. Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish women. Ann Epidemiol 2002;12:21-6.
5. McLaughlin CC, Mahoney MC, Nasca PC, et al. Breast cancer and methylxanthine consumption. Cancer Causes Control 1992;3:175-8.
6. Rosenberg L, Miller DR, Helmrich SP, et al. Breast cancer and the consumption of coffee. Am J Epidemiol 1985;122:391-9.
7. Stensvold I, Jacobsen BK. Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 1994;5:401-8.
8. Pozner J, Papatestas AE, Fagerstrom R, et al. Association of tumor differentiation with caffeine and coffee intake in women with breast cancer. Surgery 1986;100:482-8.
9. Le Marchand L, Franke AA, Custer L, Wilkens LR, Cooney RV. Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and α-tocopherol. Pharmacogenetics 1997;7:11-9.
10. Sachse C, Brockmoller J, Bauer S, Roots I. Functional significance of a C->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 1999;47:445-9.
11. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 2006;295:1135-41.
12. Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT. Characterization of the oxidative metabolites of 17β-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology 2003;144:3382-98.
13. Martucci CP, Fishman J. P450 enzymes of estrogen metabolism. Pharmacol Ther 1993;57:237-57.
14. Schneider J, Huh MM, Bradlow HL, Fishman J. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem 1984;259:4840-5.
15. Telang NT, Suto A, Wong GY, Osborne MP, Bradlow HL. Induction by estrogen metabolite 16 α-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst 1992;84:634-8.
16. Gupta M, McDougal A, Safe S. Estrogenic and antiestrogenic activities of 16α- and 2-hydroxy metabolites of 17β-estradiol in MCF-7 and T47D human breast cancer cells. J Steroid Biochem Mol Biol 1998;67:413-9.
17. Kabat GC, Chang CJ, Sparano JA, et al. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 1997;6:505-9.
18. Ho GH, Luo XW, Ji CY, Foo SC, Ng EH. Urinary 2/16 α-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein - 3 and a potential biomarker of breast cancer risk. Ann Acad Med Singapore 1998;27:294-9.
19. Meilahn EN, De Stavola B, Allen DS, et al. Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up. Br J Cancer 1998;78:1250-5.
20. Muti P, Bradlow HL, Micheli A, et al. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16a-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology 2000;11:635-40.
21. Ursin G, London S, Stanczyk FZ, et al. Urinary 2-hydroxyestrone/ 16α-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1999;91:1067-72.
22. Bradlow HL, Sepkovic DW. Diet and breast cancer. Ann N Y Acad Sci 2002;963:247-67.
23. Jernström H, Klug TL, Sepkovic DW, Bradlow HL, Narod SA. Predictors of the plasma ratio of 2-hydroxyestrone to 16α-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups. Carcinogenesis 2003;24:991-1005.
24. Bradlow HL, Jernstrom H, Sepkovic DW, Klug TL, Narod SA. Comparison of plasma and urinary levels of 2-hydroxyestrogen and 16 α-hydroxyestrogen metabolites. Mol Genet Metab 2006;87:135-46.
25. Klug TL, Bågeman E, Ingvar C, Rose C, Jernström H. Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: a pilot study comparing preand post-operative levels. Mol Genet Metab 2006;89:381-9.
26. Lurie G, Maskarinec G, Kaaks R, Stanczyk FZ, Le Marchand L. Association of genetic polymorphisms with serum estrogens measured multiple times during a 2-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev 2005;14:1521-7.
27. Kotsopoulos J, Ghadirian P, El-Sohemy A, et al. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev 2007;16:912-6.
28. Loman N, Johannsson O, Bendahl PO, et al. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer 1998;83:310-9.
29. Narod SA, Foulkes WD. BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 2004;4:665-76.
30. Yasui Y, Potter JD. The shape of age-incidence curves of female breast cancer by hormone-receptor status. Cancr Causes Control 1999;10:431-7.
31. Khoury MJ, Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol 1996;144:207-13.
32. Nordmark A, Lundgren S, Ask B, Granath F, Rane A. The effect of the CYP1A2 *1F mutation on CYP1A2 inducibility in pregnant women. Br J Clin Pharmacol 2002;54:504-10.
33. Rasmussen BB, Brix TH, Kyvik KO, Brosen K. The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors. Pharmacogenetics 2002;12:473-8.
34. Larsson SC, Giovannucci E, Wolk A. Coffee consumption and stomach cancer risk in a cohort of Swedish women. Int J Cancer 2006;119:2186-9.
35. World Resources Institute [database on the Internet]. Washington DC: World Resources Institute. EarthTrends: Environmental Information [cited 2007 Oct 11]. Available from: http://earthtrends.wri.org.
36. Butler MA, Lang NP, Young JF, et al. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 1992;2:116-27.
37. Eastman A. Cell cycle checkpoints and their impact on anticancer therapeutic strategies. J Cell Biochem 2004;91:223-31.
38. Magee PJ, Rowland IR. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 2004;91:513-31.
39. Lee WJ, Zhu BT. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 2006;27:269-77.
40. Le Marchand L, Donlon T, Kolonel LN, Henderson BE, Wilkens LR. Estrogen metabolism - related genes and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2005;14:1998-2003.
41. Zhu K, Bernard LJ, Levine RS, Williams SM. Estrogen receptor status of breast cancer: a marker of different stages of tumor or different entities of the disease? Med Hypotheses 1997;49:69-75.
42. Goodman MT, Tung KH, McDuffie K, Wilkens LR, Donlon TA. Association of caffeine intake and CYP1A2 genotype with ovarian cancer. Nutr Cancer 2003;46:23-9.